Onyx Scientific Limited

Preclinical RandD

Preclinical R&D aims to provide a safe and scalable route to small molecule API synthesis whilst generating reproducible quality material. At Onyx, we deliver phase-appropriate preclinical studies tailored to a project’s needs, with our early-phase work incorporating the production of process outlines, stress testing, impurity tracking (including PGI control) and specification setting. This creates a sound basis for later phase development where we look at more detailed specifications and impurity synthesis that will ultimately lead to process validation. We offer our customers defined work programs with a fixed budget and timeline along with milestone targets and costed assumptions that allow for transparency in scale-up estimations.